• NEDD4L, PRMT5, and CRC Liver Metastasis

  2026-09-04

  The reference study uses an in vivo E3-ligase screen to identify NEDD4L as a suppressor of colorectal cancer liver metastasis. Its mechanistic model connects NEDD4L-dependent PRMT5 degradation with reduced AKT1 arginine methylation and inhibition of AKT/mTOR signaling, providing a framework for studying metastatic colonization.

• Gemcitabine HCl: From DNA Damage to MRI

  2026-09-04

  Gemcitabine HCl research is strongest when molecular cytotoxicity and longitudinal tumor imaging are interpreted together. This article presents a decision-focused framework linking DNA replication inhibition, apoptosis, and multianimal MRI in pancreatic cancer models.

• T0070907: A Practical PPARγ Antagonist Guide

  2026-09-03

  T0070907 is a nanomolar PPARγ antagonist for separating receptor-dependent transcription from downstream phenotypes. This guide connects assay design, adipogenesis inhibition, PPARγ/RXRα heterodimer modulation, and cancer-cell-cycle workflows with practical controls and troubleshooting.

• Cyclopamine: From Hedgehog Mechanism to Translation

  2026-09-02

  A translational framework for using Cyclopamine to interrogate Smoothened-dependent biology, validate tumor responses, manage developmental risk, and connect pathway perturbation with emerging insights into inflammatory gene regulation.

• Dual-Action Inhibitors and p38α Dephosphorylation

  2026-09-02

  A 2024 preprint shows that selected kinase inhibitors can do more than occupy the p38α active site: they can also accelerate WIP1-mediated removal of the activation-loop phosphate. Structural and biochemical results support a conformation-directed model that may improve interpretation of p38 inhibition experiments, while leaving compound- and cell-specific validation essential.

• Epalrestat: Designing Polyol-Pathway Assays

  2026-09-01

  Epalrestat is an aldose reductase inhibitor that enables more precise studies of glucose-to-fructose flux, redox stress, and disease phenotypes. This article presents an assay-centered framework linking polyol pathway inhibition with diabetic neuropathy research, oxidative stress research, Parkinson’s disease models, and emerging cancer-metabolism questions.

• Isochlorogenic Acid A Hydrogel for Wound Repair

  2026-09-01

  A 2026 study developed an amylopectin/carboxymethyl chitosan hydrogel containing Isochlorogenic acid A/Fe(III) co-assembled nanoparticles to address the compound’s solubility and stability constraints in infected wound repair. The composite combined antibacterial activity, favorable physical properties, enhanced cell migration, and improved healing-associated inflammatory and vascularization markers in vitro and in vivo.

• How ARBs Reprogram Cold Tumors for Checkpoint Therapy

  2026-08-31

  The reference study identifies AGTR1 as a stromal vulnerability in collagen-rich, immune-excluded “armored and cold” tumors and shows that angiotensin receptor blockade can improve immune checkpoint blockade responses. Its key contribution is linking AT1-axis inhibition in cancer-associated fibroblasts to reduced collagen production, tumor-microenvironment remodeling, and clinical response patterns across cohorts.

• Mycophenolic acid: Reliable Cell Assay Design

  2026-08-31

  Learn how Mycophenolic acid, SKU B1981, can improve the interpretation and reproducibility of cell viability, proliferation, and immunometabolism assays. This scenario-based guide covers solvent handling, protocol optimization, data interpretation, and practical vendor selection.

• Pentoxifylline Workflows for Inflammation Research

  2026-08-30

  Pentoxifylline combines phosphodiesterase inhibition with practical utility across LPS-driven inflammation, neonatal sepsis models, psoriasis research, and sperm-motility assays. This workflow-focused guide covers concentration selection, TLR4-centered readouts, cross-domain applications, and troubleshooting for more reproducible experiments.

• Deracoxib in COX-2 Inflammation Assays

  2026-08-29

  Deracoxib is a selective COX-2 inhibitor that can help separate prostaglandin-driven effects from broader inflammatory signaling. This guide builds an assay strategy around orthogonal readouts, viability controls, and insights from a poly(I:C)-macrophage study.

• NEDD4L–PRMT5 Axis in Colorectal Cancer Metastasis

  2026-08-28

  The reference study identifies NEDD4L as an E3 ubiquitin ligase that suppresses colorectal cancer liver metastasis by targeting PRMT5 for degradation. Its in vivo screening strategy connects a defined ubiquitin-regulatory event to reduced AKT1 arginine methylation, AKT/mTOR signaling, tumor-cell proliferation, and metastatic colonization.

• XAV-939 Workflows for Wnt and Cardiac Research

  2026-08-28

  XAV-939 provides reversible tankyrase 1 and 2 inhibition for dissecting axin-dependent Wnt/β-catenin biology across cancer, fibrosis, stem-cell differentiation, and exploratory cardiac models. This workflow connects pathway pharmacology with the ATRNL1-centered cell-state findings of a large human atrial fibrillation study while clearly separating established evidence from follow-up hypotheses.

• Pentoxifylline Downregulates ICAM-1 in Monocytes

  2026-08-27

  The reference study established that Pentoxifylline suppresses ICAM-1 expression in human monocytes after oral exposure and during direct cell treatment, with reductions detectable at both protein and mRNA levels. Its TNF-α add-back and neutralization experiments linked this effect to secondary suppression of TNF-α signaling, providing a mechanistic basis for studying this phosphodiesterase inhibitor as an anti-inflammatory and immunomodulatory agent.

• T0070907: PPARγ Antagonist Workflow Guide

  2026-08-27

  T0070907 is a high-affinity PPARγ antagonist for separating receptor-dependent transcription from downstream cellular effects. This guide shows how to apply it in reporter assays, adipogenesis models, macrophage inflammation studies, and cancer cell-cycle experiments while controlling for solubility, timing, and off-target interpretation.

8009 records 1/534 page Next 12345 下5页 Last page